BioCentury
ARTICLE | Management Tracks

New CEO at Deerfield-backed Apertura

Plus 10x Genomics hires Wilbur to head commercial, and updates from Immune-Onc, PathAI, Sherlock and more

July 14, 2022 11:59 PM UTC

Joseph La Barge became CEO at Apertura Gene Therapy LLC, a Deerfield-backed company engineering AAV capsids for gene therapies. La Barge was most recently CBO at Spark Therapeutics Inc. and succeeds Dave Greenwald, VP of business development at Deerfield, who has served as CEO of Apertura since its founding. Greenwald will remain on the company’s board.

10x Genomics Inc. (NASDAQ:TXG) hired Jim Wilbur as chief commercial officer, effective July 27. Wilbur was a general manager at Mesa Scale Discovery, a provider of sensitive multiplex immunoassays...